journal
https://read.qxmd.com/read/38450794/comparison-of-continuous-24-hour-and-14-day-ecg-monitoring-for-the-detection-of-cardiac-arrhythmias-in-patients-with-ischemic-stroke-or-syncope
#21
JOURNAL ARTICLE
Wei-Cheng Chen, Yu-Lin Wu, Yu-Cheng Hsu, Jen-Te Hsu, Hung-Pin Tseng, Chao-Chin Chen, Meng-Hsiu Chiang, Ju-Feng Hsiao, See-Khong Chin, Ying-Li Huang, Meng-Huan Lei
BACKGROUND: Previous studies show that using 12-lead electrocardiogram (ECG) or 24-h ECG monitor for the detection of cardiac arrhythmia events in patients with stroke or syncope is ineffective. HYPOTHESIS: The 14-day continuous ECG patch has higher detection rates of arrhythmias compared with conventional 24-h ECG monitoring in patients with ischemic stroke or syncope. METHODS: This cross-sectional study of patients with newly diagnosed ischemic stroke or syncope received a 24-h ECG monitoring and 14-day continuous cardiac monitoring patch and the arrhythmia events were measured...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38445759/patent-foramen-ovale-closure-versus-drug-therapy-in-patients-over-60-years-and-a-follow-up-of-5-years
#22
JOURNAL ARTICLE
Angelika Eichelmann, Ralf Kubini, Dejan Nachoski, Christoph Kosinski, Michael Becker, Ali Aljalloud
BACKGROUND: The advantages of patent foramen ovale (PFO) closure as protection from a recurrence of stroke remains controversial compared to drug therapy, especially in patients over 60 years. HYPOTHESIS: The aim of the study is to compare recurrence of stroke in patients over 60 years old with PFO closure versus drug therapy alone. METHODS: We included 342 patients over 60 years who suffered a crytopgenic stroke, and were also accepted for a PFO closure...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38440948/vigorous-physical-activity-and-atrial-fibrillation-in-healthy-individuals-what-is-the-correct-approach
#23
REVIEW
Gilad Margolis, Oshri Cohen, Ariel Roguin
Sport activity compared to sedentary life is associated with improved wellbeing and risk reduction in many different health conditions including atrial fibrillation (AF). Vigorous physical activity is associated with increased AF risk. We describe four individuals, who regularly perform endurance sport activity and developed AF. We discuss the changes occurring in the heart of endurance athletes and the possible etiology for AF, as well as currently available treatment options in this seemingly healthy population...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38439605/short-time-effects-of-two-radiofrequency-ablation-methods-on-hypertrophic-obstructive-cardiomyopathy
#24
JOURNAL ARTICLE
Yin-Ge He, Yong Dong, Shao-Hua Yang, Fan Yang, Jin-Lei Yin, Hui-Qin Zhao, Yu-Jie Zhao
BACKGROUND: Radiofrequency ablation has been applied for the treatment of hypertrophic obstructive cardiomyopathy (HOCM). The two known procedures are percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) and endocardial radiofrequency septal ablation (ERSA). METHODS: This study presents a retrospective analysis of the PIMSRA and ERSA procedures in patients with drug-refractory HOCM. A total of 28 patients participated in the study, with 12 receiving PIMSRA and 16 receiving ERSA...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38436204/cardiovascular-outcomes-between-dapagliflozin-versus-empagliflozin-in-patients-with-diabetes-mellitus
#25
JOURNAL ARTICLE
Jee-Heon Kim, Young-Chae Yoon, Young-Hoon Kim, Jong-Il Park, Kang-Un Choi, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Jong-Seon Park, Ung Kim
BACKGROUND: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been demonstrated to decrease cardiovascular adverse events. However, there is little real-world clinical evidence regarding a direct comparison between dapagliflozin and empagliflozin in patients with diabetes mellitus (DM). HYPOTHESIS: A difference in the cardiovascular efficancy of dapagliflozin versus empagliflozin in DM patients was anticipated, aiming to guide the optimal choice of SGLT2 inhibitors based on cardiovascular outcomes...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38425231/correlation-between-the-serum-fabp4-angptl3-and-angptl4-levels-and-coronary-artery-disease
#26
JOURNAL ARTICLE
Zhuoyan Zhao, Ying Fu, Huan Lian, Yixiang Liu, Jingyi Liu, Lixian Sun, Ying Zhang
BACKGROUND: Lipid metabolism related factors, such as angiopoietin-like protein 3 (ANGPTL3), angiopoietin-like 4 (ANGPTL4), fatty acid-binding protein 4 (FABP4) are newly discovered factors that can affect coronary artery disease (CAD). In this study, we aimed to investigate the relationship between CAD and these lipid metabolism factors. HYPOTHESIS: ANGPTL3, ANGPTL4, and FABP4 may provide a new method for the control of CAD risk factors and the prevention and treatment of CAD...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402574/the-incidence-and-impact-of-atrial-fibrillation-on-hospitalized-coronavirus-disease-2019-patients
#27
JOURNAL ARTICLE
Haiming Niu, Jianwei Li, Catherine Teng, Xiaojia Lu, Chengyue Jin, Peng Cai, Ao Shi, Xiaoqing Shen, Qiqi Chen, Miaolian Chen, Yong Yuan, Pengyang Li
BACKGROUND: Since 2019, Coronavirus disease-2019 (COVID-19) has raised unprecedented global health crisis. The incidence and impact of atrial fibrillation (AF) on patients with COVID-19 remain unclearly defined. METHODS: We conducted a retrospective cohort study using ICD-10 codes to identify patients with a primary diagnosis of COVID-19 with or without AF in National Inpatient Sample Database 2020. We compared the outcome of COVID-19 patients with a concurrent diagnosis of AF with those without...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402573/how-to-assess-the-impact-of-diagnosis-to-ablation-time-in-patients-with-early-onset-atrial-fibrillation
#28
LETTER
Naoya Kataoka, Teruhiko Imamura
No abstract text is available yet for this article.
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402572/an-association-between-heart-rate-variability-and-incident-heart-failure-in-an-elderly-cohort
#29
JOURNAL ARTICLE
Bozena Ostrowska, Lars Lind, Carina Blomström-Lundqvist
BACKGROUND: Early identification of individuals at risk of developing heart failure (HF) may improve poor prognosis. A dominant sympathetic activity is common in HF and associated with worse outcomes; however, less is known about the autonomic balance before HF. HYPOTHESIS: A low frequency/high frequency (L-F/H-F) ratio, index of heart rate variability, and marker of the autonomic balance predict the development of HF and may improve the performance of the HF prediction model when added to traditional cardiovascular (CV) risk factors...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402570/prognostic-significance-of-il-18-in-acute-coronary-syndrome-patients
#30
JOURNAL ARTICLE
Chenchun Xiong, Qiaoting Yu, Feng Gao, Song Liu, Jianhui Zhang, Tianyi Ma, Suifeng Liu
BACKGROUND: After acute coronary syndrome (ACS), inflammation aids healing but may harm the heart. Interleukin (IL)-18 and IL-1β are pivotal proinflammatory cytokines released during pyroptosis, a process that initiates and sustains inflammation. This study aimed to evaluate the levels of circulating IL-18 and IL-1β during the progression of ACS and to determine their association with subsequent clinical events in ACS patients. HYPOTHESIS: Circulating levels of IL-18 and IL-1β are associated with subsequent clinical events in ACS patients...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402566/predicting-the-risk-of-mortality-and-rehospitalization-in-heart-failure-patients-a-retrospective-cohort-study-by-machine-learning-approach
#31
JOURNAL ARTICLE
Marzieh Ketabi, Aref Andishgar, Zhila Fereidouni, Maryam Mojarrad Sani, Ashkan Abdollahi, Mohebat Vali, Abdulhakim Alkamel, Reza Tabrizi
BACKGROUND: Heart failure (HF) is a global problem, affecting more than 26 million people worldwide. This study evaluated the performance of 10 machine learning (ML) algorithms and chose the best algorithm to predict mortality and readmission of HF patients by using The Fasa Registry on Systolic HF (FaRSH) database. HYPOTHESIS: ML algorithms may better identify patients at increased risk of HF readmission or death with demographic and clinical data. METHODS: Through comprehensive evaluation, the best-performing model was used for prediction...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402565/the-prognostic-value-of-the-visually-assessed-time-difference-between-mitral-valve-and-tricuspid-valve-opening-score-for-patients-with-heart-failure-with-mildly-reduced-ejection-fraction
#32
JOURNAL ARTICLE
Yin Yue, Xiaopeng Wu, Xiaonan Guan, Xuejiao Wu, Jianjun Zhang
BACKGROUND: The visually assessed time difference between the mitral valve and tricuspid valve opening (VMT) score was correlated with the increase of left ventricular filling pressure (LVFP). HYPOTHESIS: We suspected that the VMT score might be a valuable prognostic biomarker for heart failure with mildly reduced ejection fraction (HFmrEF) patients. This study was to evaluate the predictive value of VMT score for 1-year all-cause and cardiovascular disease (CVD)-cause mortality in HFmrEF patients...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402564/optimal-catheter-ablation-procedure-for-premature-ventricular-contraction-originating-from-the-free-wall-of-tricuspid-annulus
#33
LETTER
Naoya Kataoka, Teruhiko Imamura
No abstract text is available yet for this article.
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402563/a-novel-contact-force-sensing-pulsed-field-ablation-catheter-in-a-porcine-model
#34
JOURNAL ARTICLE
Juan Hua, Qinmei Xiong, Qiling Kong, Liang Xiong, Qianghui Huang, Jinzhu Hu, Juxiang Li, Jianxin Hu, Peng Si, Tuo Zhou, Qi Chen
BACKGROUND: Pulsed field ablation (PFA) has emerged as a novel non-thermal modality with highly myocardium-specific. However, the PFA catheter based on contact force (CF)-sensing has not been reported. The study aimed to evaluate the efficacy and safety of a novel CF-sensing PFA catheter. METHODS: First, different CF (5, 15, 25, and 35 g) of the novel PFA catheter were evaluated on lesion dimensions during ablation on right and left ventricle in two pigs...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402557/a-higher-non-hdl-c-hdl-c-ratio-was-associated-with-an-increased-risk-of-progression-of-nonculprit-coronary-lesion-in-patients-with-acute-coronary-syndrome-undergoing-percutaneous-coronary-intervention
#35
JOURNAL ARTICLE
Jiamin Liu, Li Zhao, Yazhou Zhang, Lili Wang, Qianqian Feng, Jing Cui, Wenhong Zhang, Jianyong Zheng, Dan Wang, Fengjiao Zhao, Jiangchun He, Yu Chen
BACKGROUND: The ratio of nonhigh-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) has been shown associated with various metabolic diseases and atherosclerosis in primary prevention. However, there is limited evidence on the relationship between the non-HDL-C/HDL-C ratio and progression of nonculprit coronary lesion (NCCL) after percutaneous coronary intervention (PCI). HYPOTHESIS: Our study aimed to investigate the potential association between the non-HDL-C/HDL-C ratio and NCCL progression in patients with acute coronary syndrome (ACS) undergoing PCI...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402556/impact-of-different-sequential-triple-oral-combination-therapies-based-selexipag-on-outcomes-in-pulmonary-arterial-hypertension
#36
JOURNAL ARTICLE
Xiaoyi Hu, Ping Yuan, Jun Chen, Shang Wang, Hui Zhao, Yaqin Wei, Jiaqi Fu, Fadong Chen, Hongyun Ruan, Wei Zhang, Yanli Zhou, Qiqi Wang, Xiaoling Xu, Kefu Feng, Jianzhou Guo, Sugang Gong, Ruifeng Zhang, Qinhua Zhao, Lan Wang
BACKGROUND: While the GRIPHON study and others have confirmed the efficacy and safety of selexipag with single, dual, and initial triple combination therapy for patients with pulmonary arterial hypertension (PAH), multicenters studies concerning diverse triple oral combination therapies based on selexipag are limited. HYPOTHESIS: This study was conducted to evaluate the effects of various sequential triple oral combination therapies on PAH outcomes. METHODS: A retrospective study was carried out involving 192 patients from 10 centers, who were receiving sequential triple oral combination therapy consisting of an endothelin receptor antagonist (ERA), a phosphodiesterase 5 inhibitor (PDE5i)/riociguat and selexipag...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402554/reply-how-well-can-frailty-predict-no-benefit-from-icd-therapy
#37
LETTER
Michael Gotzmann, Marie Lewenhardt, Fabienne Kreimer
No abstract text is available yet for this article.
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402553/establishment-and-validation-of-a-prediction-model-for-nonrecovery-of-left-ventricular-ejection-fraction-in-acute-myocardial-infarction-patients-combined-with-decreased-left-ventricular-ejection-fraction
#38
JOURNAL ARTICLE
Yang Yang, You Zheng Dong, An Xue Hou, De Ping Liu, Jin Wu He, Jun Ye Chen, Xing Hua Jiang
BACKGROUND: This study aimed to investigate the risk factors for nonrecovery of left ventricular ejection fraction (LVEF) during follow-up in patients with acute myocardial infarction (AMI) who underwent percutaneous coronary intervention (PCI) combined with reduced LVEF, and establish and verify a risk prediction model based on these factors. METHODS: In this study, patients with AMI who underwent PCI in a high-volume PCI center between December 2018 and December 2021 were consecutively enrolled, screened, and randomly assigned to the model establishment and validation cohorts...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402552/the-effect-of-kidney-function-on-guideline-directed-medical-therapy-implementation-and-prognosis-in-heart-failure-with-reduced-ejection-fraction
#39
JOURNAL ARTICLE
Fanni Bánfi-Bacsárdi, Dávid Pilecky, Máté Vámos, Zsuzsanna Majoros, Gábor Márton Török, Tünde Dóra Borsányi, Miklós Dékány, Balázs Solymossi, Péter Andréka, Gábor Zoltán Duray, Róbert Gábor Kiss, Noémi Nyolczas, Balázs Muk
BACKGROUND: Kidney dysfunction (KD) is a main limiting factor of applying guideline-directed medical therapy (GDMT) and reaching the recommended target doses (TD) in heart failure (HF) with reduced ejection fraction (HFrEF). HYPOTHESIS: We aimed to assess the success of optimization, long-term applicability, and adherence of neurohormonal antagonist triple therapy (TT:RASi [ACEi/ARB/ARNI] + βB + MRA) according to the KD after a HF hospitalization and to investigate its impact on prognosis...
February 2024: Clinical Cardiology
https://read.qxmd.com/read/38402549/lactate-dehydrogenase-to-albumin-ratio-a-superior-inflammatory-marker-for-predicting-contrast-associated-acute-kidney-injury-after-percutaneous-coronary-intervention
#40
JOURNAL ARTICLE
Ji-Lang Zeng, Jun-Han Chen, Li-Wei Zhang, Li-Chuan Chen, Wen-Jia Liang, Zhebin You, Kai-Yang Lin, Yansong Guo
PURPOSE: Inflammation is commonly considered a mechanism underlying contrast-associated acute kidney injury (CA-AKI). This study aimed to explore the predictive capability of the novel inflammatory marker lactate dehydrogenase-to-albumin ratio (LAR) for CA-AKI following percutaneous coronary intervention (PCI), and further compare it with other common inflammatory biomarkers. METHODS: This study enrolled 5,435 patients undergoing elective PCI. The primary outcome was CA-AKI, and the secondary outcome was all-cause mortality...
February 2024: Clinical Cardiology
journal
journal
27597
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.